| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0015 | 1 |